Are Mobile Persons With Parkinson Disease Necessarily More Active?
- PMID: 34091569
- PMCID: PMC8460597
- DOI: 10.1097/NPT.0000000000000362
Are Mobile Persons With Parkinson Disease Necessarily More Active?
Abstract
Background and purpose: Walking activity in persons with Parkinson disease (PD) is important for preventing functional decline. The contribution of walking activity to home and community mobility in PD is poorly understood.
Methods: Cross-sectional baseline data (N = 69) were analyzed from a randomized controlled PD trial. The Life-Space Assessment (LSA) quantified the extent, frequency, and independence across 5 expanding levels of home and community mobility, producing individual subscores and a total score. Two additional summed scores were used to represent mobility within (Levels 1-3) and beyond (Levels 4-5) neighborhood limits. An accelerometer measured walking activity for 7 days. Regression and correlation analyses evaluated relationships between daily steps and mobility scores. Mann-Whitney U tests secondarily compared differences in mobility scores between the active and sedentary groups.
Results: Walking activity contributed significantly to the summed Level 1-3 score (β = 0.001, P = 0.004) but not to the summed Level 4-5 (β = 0.001, P = 0.33) or total (β = 0.002, P = 0.07) scores. Walking activity was significantly related to Level 1 (ρ = 0.336, P = 0.005), Level 2 (ρ = 0.307, P = 0.010), and Level 3 (ρ = 0.314, P = 0.009) subscores. Only the summed Level 1-3 score (P = 0.030) was significantly different between the active and sedentary groups.
Discussion and conclusions: Persons with PD who demonstrated greater mobility beyond the neighborhood were not necessarily more active; walking activity contributed more so to home and neighborhood mobility. Compared with LSA total score, the Level 1-3 summed score may be a more useful participation-level measure for assessing the impact of changes in walking activity.Video Abstract available for more insights from the authors (see the Video, Supplemental Digital Content 1 available at: http://links.lww.com/JNPT/A349).
Trial registration: ClinicalTrials.gov NCT03517371.
Copyright © 2021 Academy of Neurologic Physical Therapy, APTA.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- Skantz H, Rantanen T, Palmberg L, Rantalainen T, Aartolahti E, Portegijs E et al.Outdoor mobility and use of adaptive or maladaptive walking modifications among older people. The Gerontological Society of America 2020;75(4):806–812. - PubMed
-
- Ellis TD, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Thackeray A, Thiese MS, Dibble LE. Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease. Parkinsonism Relat Disord 2016;25:65–71. - PubMed
-
- Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS et al.The evolution of disability in Parkinson disease. Movement Disorders. 2008;23(6):790–796. - PubMed
-
- Shulman LM. Understanding disability in Parkinson’s disease. Movement Disorders. 2010;25(1):131–135. - PubMed